BioCentury | Aug 2, 2010
Clinical News

Ashkenazi Jews Genetic Disease Panel regulatory update

Last month, FDA sent letters to 14 companies that market genetic testing kits notifying them that the tests have not received clearance from the agency. The agency requested a response within 15 days. Earlier in...
BioCentury | Aug 10, 2009
Company News

CyGene sales and marketing update

CyGene launched its direct-to-consumer genetic screening tests in Russia to predict the risk of stroke, cardiovascular disease, Type II diabetes and obesity, glaucoma and macular degeneration, osteoporosis and autoimmune diseases. CyGene Laboratories Inc. (Pink:CYGE), Coral...
BioCentury | Jul 28, 2008
Company News

CyGene sales and marketing update

CyGene launched its StrokeScan genetic screening test worldwide to identify high risk individuals who have a family history of stroke, cardiovascular or kidney disease. The test has CLIA certification and is priced at $499. CyGene...
BioCentury | Jan 8, 2007
Strategy

Thinking globally

...company CSL (ASX:CSL) Has global operations for developing, manufacturing and marketing vaccines and blood products CyGenics...
BioCentury | Sep 18, 2006
Company News

CyGenics gene/cell therapy news

...cord blood banking business. The company said it will continue to expand these businesses globally. CyGenics Ltd....
BioCentury | Sep 11, 2006
Company News

CyGenics, DNAPro Sdn Bhd deal

...20% stake in DNAPro. CYN said the equity stake is valued at about A$450,000 (US$347,265). CyGenics Ltd....
BioCentury | Jun 12, 2006
Company News

CyGenics, PharmaCell deal

...European market and will allow it to provide cell therapy manufacturing services to third parties. CyGenics Ltd....
BioCentury | Feb 20, 2006
Company News

CyGenics board of directors update

CyGenics Ltd. (ASX:CYN), Melbourne, Australia Business: Gene/Cell therapy Appointed: Alberto Bautista, an industry consultant WIR Staff...
BioCentury | Dec 19, 2005
Company News

CyGenics management update

CyGenics Ltd. (ASX:CYN), Sydney, Australia Business: Gene/Cell therapy Hired: Mark Kirkland as CSO, formerly CEO of BioCell Pty Ltd. WIR Staff...
BioCentury | Dec 12, 2005
Clinical News

CyGenics preclinical data

...generates T cells from autologous skin cells and bone marrow stem cells for clinical transplantation. CyGenics Ltd....
Items per page:
1 - 10 of 14
BioCentury | Aug 2, 2010
Clinical News

Ashkenazi Jews Genetic Disease Panel regulatory update

Last month, FDA sent letters to 14 companies that market genetic testing kits notifying them that the tests have not received clearance from the agency. The agency requested a response within 15 days. Earlier in...
BioCentury | Aug 10, 2009
Company News

CyGene sales and marketing update

CyGene launched its direct-to-consumer genetic screening tests in Russia to predict the risk of stroke, cardiovascular disease, Type II diabetes and obesity, glaucoma and macular degeneration, osteoporosis and autoimmune diseases. CyGene Laboratories Inc. (Pink:CYGE), Coral...
BioCentury | Jul 28, 2008
Company News

CyGene sales and marketing update

CyGene launched its StrokeScan genetic screening test worldwide to identify high risk individuals who have a family history of stroke, cardiovascular or kidney disease. The test has CLIA certification and is priced at $499. CyGene...
BioCentury | Jan 8, 2007
Strategy

Thinking globally

...company CSL (ASX:CSL) Has global operations for developing, manufacturing and marketing vaccines and blood products CyGenics...
BioCentury | Sep 18, 2006
Company News

CyGenics gene/cell therapy news

...cord blood banking business. The company said it will continue to expand these businesses globally. CyGenics Ltd....
BioCentury | Sep 11, 2006
Company News

CyGenics, DNAPro Sdn Bhd deal

...20% stake in DNAPro. CYN said the equity stake is valued at about A$450,000 (US$347,265). CyGenics Ltd....
BioCentury | Jun 12, 2006
Company News

CyGenics, PharmaCell deal

...European market and will allow it to provide cell therapy manufacturing services to third parties. CyGenics Ltd....
BioCentury | Feb 20, 2006
Company News

CyGenics board of directors update

CyGenics Ltd. (ASX:CYN), Melbourne, Australia Business: Gene/Cell therapy Appointed: Alberto Bautista, an industry consultant WIR Staff...
BioCentury | Dec 19, 2005
Company News

CyGenics management update

CyGenics Ltd. (ASX:CYN), Sydney, Australia Business: Gene/Cell therapy Hired: Mark Kirkland as CSO, formerly CEO of BioCell Pty Ltd. WIR Staff...
BioCentury | Dec 12, 2005
Clinical News

CyGenics preclinical data

...generates T cells from autologous skin cells and bone marrow stem cells for clinical transplantation. CyGenics Ltd....
Items per page:
1 - 10 of 14